TomEnterprise AB's Form 4 filing
DiaMedica Therapeutics Inc. (DMAC) · filed Jul 21, 2022
- Accession no.
- 0001567619-22-014290
- Filed
- Jul 21, 2022, 1:06 PM ET
- Trade date
- Jul 8, 2022
- Filing delay
- 13 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $275.9K. It was filed 13 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| TomEnterprise ABCIK 0001887435 | 10% Owner |
| Von Koch ThomasCIK 0001938915 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2022 | Common Shares | PPurchaseAcquired | +207,974 | $1.33 | +$275,898.31 | 2,855,827 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.